Search

Your search keyword '"Franco, Rafael"' showing total 121 results

Search Constraints

Start Over You searched for: Author "Franco, Rafael" Remove constraint Author: "Franco, Rafael" Publisher elsevier bv Remove constraint Publisher: elsevier bv
121 results on '"Franco, Rafael"'

Search Results

2. The cannabinoid CB1 receptor interacts with the angiotensin AT2 receptor. Overexpression of AT2-CB1 receptor heteromers in the striatum of 6-hydroxydopamine hemilesioned rats

3. Pulmonary Thromboendarterectomy in Klinefelter Syndrome. Literature Review

4. Postweaning Enriched Environment Enhances Cognitive Function and Brain-Derived Neurotrophic Factor Signaling in the Hippocampus in Maternally Separated Rats

6. Adenosine/A2B Receptor Signaling Ameliorates the Effects of Aging and Counteracts Obesity

8. Pulmonary Thromboendarterectomy in Klinefelter Syndrome. Literature Review

10. Similarities and differences upon binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors

11. An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria

13. The Heteromeric Complex Formed by Dopamine Receptor D5 and CCR9 Leads the Gut Homing of CD4+ T Cells Upon Inflammation

14. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors

17. Adenosine/A2B Receptor Signaling Ameliorates the Effects of Aging and Counteracts Obesity

21. Hyperosmolarity-induced vasopressin expression and intrinsic excitability of supraoptic neurons of adult offspring are changed by early maternal separation

23. Differential effect of amphetamine over the corticotropin-releasing factor CRF2 receptor, the orexin OX1 receptor and the CRF2-OX1 heteroreceptor complex

24. Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes

25. Molecular and functional interaction between GPR18 and cannabinoid CB2 G-protein-coupled receptors. Relevance in neurodegenerative diseases

26. Twelve years of experience with miglustat in the treatment of type 1 Gaucher disease: The Spanish ZAGAL project

27. Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and levodopa-induced dyskinesia

29. GPR55: A therapeutic target for Parkinson's disease?

31. Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease

32. Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson’s disease

37. A liberal strategy of red blood cell transfusion reduces cardiogenic shock in elderly patients undergoing cardiac surgery

42. l-DOPA-treatment in primates disrupts the expression of A2A adenosine–CB1 cannabinoid–D2 dopamine receptor heteromers in the caudate nucleus

43. l-DOPA disrupts adenosine A2A–cannabinoid CB1–dopamine D2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies

44. Mechanisms of cannabidiol neuroprotection in hypoxic–ischemic newborn pigs: Role of 5HT1A and CB2 receptors

46. Tadalafil crosses the blood–brain barrier and reverses cognitive dysfunction in a mouse model of AD

48. Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain

Catalog

Books, media, physical & digital resources